| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cure for HIV: where we've been, and where we're headed
|
Lewin, Sharon R
|
|
2013
|
381 |
9883 |
p. 2057-2058
2 p.
|
artikel
|
| 2 |
Addressing NCDs: is it really a global coalition?
|
Carrillo-Larco, Rodrigo M
|
|
2013
|
381 |
9883 |
p. 2081-
1 p.
|
artikel
|
| 3 |
Addressing NCDs: is it really a global coalition? – Authors' reply
|
Beaglehole, Robert
|
|
2013
|
381 |
9883 |
p. 2081-2082
2 p.
|
artikel
|
| 4 |
Adeeba Kamarulzaman: fighting HIV/AIDS in Malaysia
|
Shetty, Priya
|
|
2013
|
381 |
9883 |
p. 2073-
1 p.
|
artikel
|
| 5 |
After first-line ART: towards an evidence-based SECOND-LINE
|
Soria, Alessandro
|
|
2013
|
381 |
9883 |
p. 2062-2063
2 p.
|
artikel
|
| 6 |
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
|
Choopanya, Kachit
|
|
2013
|
381 |
9883 |
p. 2083-2090
8 p.
|
artikel
|
| 7 |
Autologous HSCT for systemic sclerosis
|
van Laar, Jacob M
|
|
2013
|
381 |
9883 |
p. 2079-2080
2 p.
|
artikel
|
| 8 |
Autologous HSCT for systemic sclerosis
|
Sakellari, Ioanna
|
|
2013
|
381 |
9883 |
p. 2080-
1 p.
|
artikel
|
| 9 |
Autologous HSCT for systemic sclerosis – Authors'reply
|
Burt, Richard K
|
|
2013
|
381 |
9883 |
p. 2080-2081
2 p.
|
artikel
|
| 10 |
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
|
Katlama, Christine
|
|
2013
|
381 |
9883 |
p. 2109-2117
9 p.
|
artikel
|
| 11 |
Department of Error
|
|
|
2013
|
381 |
9883 |
p. 2082-
1 p.
|
artikel
|
| 12 |
Department of Error
|
|
|
2013
|
381 |
9883 |
p. 2082-
1 p.
|
artikel
|
| 13 |
During Turkish protests, medical personnel targeted
|
Name and address supplied,
|
|
2013
|
381 |
9883 |
p. 2067-
1 p.
|
artikel
|
| 14 |
Fighting the HIV epidemic in the Islamic world
|
Kamarulzaman, Adeeba
|
|
2013
|
381 |
9883 |
p. 2058-2060
3 p.
|
artikel
|
| 15 |
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening
|
Balabanova, Dina
|
|
2013
|
381 |
9883 |
p. 2118-2133
16 p.
|
artikel
|
| 16 |
Hepatitis C treatment: interferon free or interferon freer?
|
Dusheiko, Geoffrey
|
|
2013
|
381 |
9883 |
p. 2063-2065
3 p.
|
artikel
|
| 17 |
HIV pre-exposure prophylaxis in injecting drug users
|
Karim, Salim S Abdool
|
|
2013
|
381 |
9883 |
p. 2060-2062
3 p.
|
artikel
|
| 18 |
Human co-infection with novel avian influenza A H7N9 and influenza A H3N2 viruses in Jiangsu province, China
|
Zhu, Yefei
|
|
2013
|
381 |
9883 |
p. 2134-
1 p.
|
artikel
|
| 19 |
Jaccoud's arthropathy
|
Chaurasia, Ajay S
|
|
2013
|
381 |
9883 |
p. 2108-
1 p.
|
artikel
|
| 20 |
June 15–21, 2013
|
|
|
2013
|
381 |
9883 |
p. i-
1 p.
|
artikel
|
| 21 |
Loving the alien
|
Boyce, Niall
|
|
2013
|
381 |
9883 |
p. 2075-
1 p.
|
artikel
|
| 22 |
Malaysia makes progress against HIV, but challenges remain
|
Barmania, Sima
|
|
2013
|
381 |
9883 |
p. 2070-2071
2 p.
|
artikel
|
| 23 |
MERS-CoV: in search of answers
|
Petherick, Anna
|
|
2013
|
381 |
9883 |
p. 2069-
1 p.
|
artikel
|
| 24 |
Offline: The RCPCH—defending children's health
|
Horton, Richard
|
|
2013
|
381 |
9883 |
p. 2068-
1 p.
|
artikel
|
| 25 |
Open access policy
|
Glynn, Judith R
|
|
2013
|
381 |
9883 |
p. 2082-
1 p.
|
artikel
|
| 26 |
Open access policy – Authors' reply
|
The Lancet Editors,
|
|
2013
|
381 |
9883 |
p. 2082-
1 p.
|
artikel
|
| 27 |
Profile: IAVI—searching for the Achilles' heel of HIV
|
Holmes, David
|
|
2013
|
381 |
9883 |
p. 2072-
1 p.
|
artikel
|
| 28 |
Public and global engagement with global health
|
Friberg, Peter
|
|
2013
|
381 |
9883 |
p. 2066-
1 p.
|
artikel
|
| 29 |
Reducing gun violence: facts are stubborn things
|
The Lancet,
|
|
2013
|
381 |
9883 |
p. 2055-
1 p.
|
artikel
|
| 30 |
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study
|
|
|
2013
|
381 |
9883 |
p. 2091-2099
9 p.
|
artikel
|
| 31 |
Sex, death, disease, and social change
|
Leclerc-Madlala, Suzanne
|
|
2013
|
381 |
9883 |
p. 2074-2075
2 p.
|
artikel
|
| 32 |
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
|
Kowdley, Kris V
|
|
2013
|
381 |
9883 |
p. 2100-2107
8 p.
|
artikel
|
| 33 |
Tamoxifen therapy for patients with breast cancer
|
Neven, Patrick
|
|
2013
|
381 |
9883 |
p. 2078-
1 p.
|
artikel
|
| 34 |
Tamoxifen therapy for patients with breast cancer
|
Huiart, Laetitia
|
|
2013
|
381 |
9883 |
p. 2077-
1 p.
|
artikel
|
| 35 |
Tamoxifen therapy for patients with breast cancer
|
Litton, Jennifer
|
|
2013
|
381 |
9883 |
p. 2077-2078
2 p.
|
artikel
|
| 36 |
Tamoxifen therapy for patients with breast cancer – Authors' reply
|
Davies, Christina
|
|
2013
|
381 |
9883 |
p. 2078-2079
2 p.
|
artikel
|
| 37 |
The right to health for Syrian refugees
|
The Lancet,
|
|
2013
|
381 |
9883 |
p. 2056-
1 p.
|
artikel
|
| 38 |
Timothy Grant Manchester
|
Pincock, Stephen
|
|
2013
|
381 |
9883 |
p. 2076-
1 p.
|
artikel
|
| 39 |
30 years of HIV: where next?
|
The Lancet,
|
|
2013
|
381 |
9883 |
p. 2056-
1 p.
|
artikel
|
Tijdschrift beschrijving